SEC Form 4 · accession 0001104659-15-059918
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Thomas J. Lowery
Officer — Chief Scientific Officer
Period of report
Aug 12, 2015
Accepted (ET)
Aug 14, 2015 · 11:36 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 12, 2015 | M | 2,000 | $2.45 | D | 6,411 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.45 | Aug 12, 2015 | M | 2,000 | D | — | Jan 17, 2022 | Common Stock | 2,000 | 36,235 | D |
Explanation of responses
- F1The Stock Option vested as to 25% of the underlying shares on January 17, 2013 and the remaining shares vested or will vest in 36 equal monthly installments thereafter.